Clinical trials recruiting for MCI-AD, Early Stage Alzheimer's Disease
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
2
Countries
50%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 4 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Conventional anti-dementia treatment group | 1 |
| Dimethyl Fumarate | 1 |
| Lecanemab 10 mg/kg | 1 |
Self-screener
Recruiting trials
- Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease
- Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
Related conditions
Trials recruiting for MCI-AD, Early Stage Alzheimer's Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for MCI-AD, Early Stage Alzheimer's Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.